Chief Financial Officer Roger Thompson sold 18,000 shares of Janus Henderson Group PLC (NYSE:JHG) on September 12, 2024, as reported in a recent SEC Filing. Following this transaction, the insider now owns 130,171.03 shares of the company.
Janus Henderson Group PLC is a global asset management group managing assets for institutional, retail, and high net-worth clients. It offers a broad range of financial products and services, including equities, fixed income, property, and private equity.
Over the past year, Roger Thompson has sold a total of 48,656 shares and has not made any purchases of the company’s stock. This recent transaction is part of a broader trend observed within the company, where there have been 7 insider sells and no insider buys over the past year.
On the day of the sale, shares of Janus Henderson Group PLC were trading at $35.49. This pricing gives the company a market cap of approximately $5.70 billion. The price-earnings ratio of the stock stands at 12.28, slightly above the industry median of 11.96 and the company’s historical median.
According to the GF Value, the intrinsic value estimate for Janus Henderson Group PLC is $30.49 per share, making the stock modestly overvalued with a price-to-GF-Value ratio of 1.16. The GF Value is calculated based on historical trading multiples, a GuruFocus adjustment factor, and future business performance estimates.
This insider sale might interest investors tracking insider behaviors as an indicator of the company’s future performance and valuation alignment.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
